The first-in-human clinical trial of nanoformed piroxicam will begin in late 2020, with results expected by mid-2021.
List view / Grid view
Filter the results
New investment provides substantial new funding to fuel the next stage of Quotient’s growth.
Quotient Clinical, the drug development services organisation, announces its renaming to Quotient Sciences (Quotient), following the acquisitions of Co-Formulate, QS Pharma and SeaView Research...